Tania F Gendron, Eric Brunette, Joseph S Tauskela, Paul Morley
Index: Eur. J. Pharmacol. 517(1-2) , 17-27, (2005)
Full Text: HTML
Cyclooxygenase-2 is harmful in models of cerebral ischemia yet plays a protective role in preconditioning-induced ischemic tolerance in the heart. This study examined the mechanisms underlying cyclooxygenase-2-mediated neurotoxicity and preconditioning-induced neuroprotection in an in vitro model of cerebral ischemia. Inhibition of cyclooxygenase-2 protects cortical neuronal cultures from death induced by oxygen-glucose deprivation and reduces oxygen-glucose deprivation-induced increases in intracellular Ca(2+) ([Ca(2+)](i)). In the present study, we determined if prostaglandin E(2) (PGE(2)) is responsible for this cyclooxygenase-2-mediated effect. Rat cortical cultures expressed mRNA for the prostanoid EP(1)-EP(4) receptors. PGE(2) reversed the attenuation in [Ca(2+)](i) and the protection offered by cyclooxygenase-2 inhibition during oxygen-glucose deprivation. These effects likely occur via activation of the prostanoid EP(1) receptor since blocking this receptor during oxygen-glucose deprivation reduced [Ca(2+)](i) and neurotoxicity. Next, we considered if the moderate activation of this pathway, by preconditioning cultures with sub-lethal oxygen-glucose deprivation, influenced the development of tolerance to an otherwise lethal oxygen-glucose deprivation insult, 48 h later. Inhibition of cyclooxygenase-2 during oxygen-glucose deprivation-preconditioning abolished preconditioning-induced protection. Furthermore, cultures were rendered tolerant to oxygen-glucose deprivation by the transient exposure to exogenous PGE(2) 24 h prior to the insult, indicating that this product of the cyclooxygenase-2 pathway is sufficient to induce ischemic tolerance. This study shows that cyclooxygenase-2 and PGE(2) are involved in both oxygen-glucose deprivation-induced neurotoxicity and preconditioning-induced neuroprotection. While neurotoxic in the context of lethal oxygen-glucose deprivation, the moderate activation of this signalling pathway confers ischemic tolerance.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
SC 19220
CAS:19395-87-0 |
C16H14ClN3O3 | |
![]() |
SC-58125
CAS:162054-19-5 |
C17H12F4N2O2S |
|
The role of prostaglandin E and thromboxane-prostanoid recep...
2008-04-01 [Cardiovasc. Res. 78(1) , 130-8, (2008)] |
|
Prostanoid receptors involved in regulation of the beating r...
2012-01-01 [PLoS ONE 7(9) , e45273, (2012)] |
|
Prostaglandin E₂ possesses different potencies in inducing V...
2016-03-01 [Prostaglandins Leukot. Essent. Fatty Acids 106 , 11-Aug, (2016)] |
|
The prostaglandin E2 analogue sulprostone antagonizes vasopr...
2003-08-15 [J. Cell Sci. 116(Pt 16) , 3285-94, (2003)] |
|
Acute effects of prostaglandin E1 and E2 on vascular reactiv...
2012-01-01 [Prostaglandins Leukot. Essent. Fatty Acids 87(2-3) , 79-89, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved

